Ontology type: schema:MonetaryGrant
2010-2015
FUNDING AMOUNT16447515 USD
ABSTRACTThe overall goal of this PEN application is the development and imaging-facilitated evaluation of translational nanotechnology-based tools, and the development of associated multidisciplinary trainees, focused on the treatment of heart failure and atherosclerosis. We will apply nanotechnology to address the aforementioned cardiovascular diseases and integrate expertise in multiple disciplines, including vascular biology, tissue engineering, drug delivery, molecular biology, diagnostic imaging, chemistry, physics, bioengineering, and clinical sciences. Our multidisciplinary team includes investigators from Mount Sinai School of Medicine (MSSM), Massachusetts Institute of Technology (MIT), New York University (NYU), Columbia University (Columbia), and Brigham and Women's Hospital (BWH). Under the leadership of Zahi Fayad (MSSM) and Robert Langer (MIT), the application is structured to facilitate a synergistic interaction among the different investigators, to maximize clinical translation of the nanotechnology to biomedical and clinical problems, to optimize the design of nanotechnology components, and to train the next generation of engineers, scientists, and clinicians with the multidisciplinary skills to exploit nanotechnology towards eliminating the burdens of cardiovascular disease. The program consists of 3 innovative and translational research projects that utilize nanotechnology to tackle specific cardiac and vascular problems and thereby treat cardiovascular disease. Project 1 (Hajjar, Langer, Costa) will investigate minimally invasive nanotechnology-based approaches to deliver regeneration factors to the infarcted myocardium. In Project 2 (Fisher, Tabas, Langer, Farokhzad) novel nanotherapeutic approaches for defective inflammation resolution in atherosclerosis will be developed. Project 3 (Fayad, Mulder, Fuster, Langer) will develop a theranostic nanoparticle platform with surface activation properties to efficiently and specifically target and image macrophages in atherosclerotic plaques. All projects have a high degree of translational potential as well as a strong emphasis on developing state-of-the-art nanotechnology, with the balance between translation and technology varying among the 3 projects to create attractive and diverse platforms that are aligned with the overall goal of the NHLBI Programs of Excellence in Nanotechnology. Moreover, we chose to focus the different projects at two stages of cardiovascular disease, namely the (early) atherosclerotic inflammatory process and (late) myocardial regeneration after infarction. All 3 projects offer outstanding opportunities for the training and professional development of graduate students and postdoctoral fellows with the multidisciplinary skills required to apply nanotechnology in the context of cardiovascular disease. More... »
URLhttp://projectreporter.nih.gov/project_info_description.cfm?aid=8175621
http://scigraph.springernature.com/grant.2345462
DIMENSIONShttps://app.dimensions.ai/details/grant/grant.2345462
NIH268201000045C-0-0-1
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2209",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"type": "DefinedTerm"
}
],
"amount": {
"currency": "USD",
"type": "MonetaryAmount",
"value": "16447515"
},
"description": "The overall goal of this PEN application is the development and imaging-facilitated evaluation of translational nanotechnology-based tools, and the development of associated multidisciplinary trainees, focused on the treatment of heart failure and atherosclerosis. We will apply nanotechnology to address the aforementioned cardiovascular diseases and integrate expertise in multiple disciplines, including vascular biology, tissue engineering, drug delivery, molecular biology, diagnostic imaging, chemistry, physics, bioengineering, and clinical sciences. Our multidisciplinary team includes investigators from Mount Sinai School of Medicine (MSSM), Massachusetts Institute of Technology (MIT), New York University (NYU), Columbia University (Columbia), and Brigham and Women's Hospital (BWH). Under the leadership of Zahi Fayad (MSSM) and Robert Langer (MIT), the application is structured to facilitate a synergistic interaction among the different investigators, to maximize clinical translation of the nanotechnology to biomedical and clinical problems, to optimize the design of nanotechnology components, and to train the next generation of engineers, scientists, and clinicians with the multidisciplinary skills to exploit nanotechnology towards eliminating the burdens of cardiovascular disease. The program consists of 3 innovative and translational research projects that utilize nanotechnology to tackle specific cardiac and vascular problems and thereby treat cardiovascular disease. Project 1 (Hajjar, Langer, Costa) will investigate minimally invasive nanotechnology-based approaches to deliver regeneration factors to the infarcted myocardium. In Project 2 (Fisher, Tabas, Langer, Farokhzad) novel nanotherapeutic approaches for defective inflammation resolution in atherosclerosis will be developed. Project 3 (Fayad, Mulder, Fuster, Langer) will develop a theranostic nanoparticle platform with surface activation properties to efficiently and specifically target and image macrophages in atherosclerotic plaques. All projects have a high degree of translational potential as well as a strong emphasis on developing state-of-the-art nanotechnology, with the balance between translation and technology varying among the 3 projects to create attractive and diverse platforms that are aligned with the overall goal of the NHLBI Programs of Excellence in Nanotechnology. Moreover, we chose to focus the different projects at two stages of cardiovascular disease, namely the (early) atherosclerotic inflammatory process and (late) myocardial regeneration after infarction. All 3 projects offer outstanding opportunities for the training and professional development of graduate students and postdoctoral fellows with the multidisciplinary skills required to apply nanotechnology in the context of cardiovascular disease.",
"endDate": "2015-08-12T00:00:00Z",
"funder": {
"id": "https://www.grid.ac/institutes/grid.279885.9",
"type": "Organization"
},
"id": "sg:grant.2345462",
"identifier": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"2345462"
]
},
{
"name": "nih_id",
"type": "PropertyValue",
"value": [
"268201000045C-0-0-1"
]
}
],
"inLanguage": [
"en"
],
"keywords": [
"myocardium",
"multiple disciplines",
"approach",
"physics",
"invasive nanotechnology",
"scientists",
"outstanding opportunity",
"Mount Sinai School",
"molecular biology",
"expertise",
"translational research projects",
"development",
"different projects",
"professional development",
"atherosclerotic plaques",
"clinical problems",
"high degree",
"vascular problems",
"diverse platforms",
"surface activation properties",
"program",
"BWH",
"Fayad",
"Mulder",
"macrophages",
"overall goal",
"strong emphasis",
"design",
"translation",
"application",
"nanotherapeutic approaches",
"leadership",
"chemistry",
"Robert Langer",
"novel",
"multidisciplinary team",
"graduate students",
"clinical science",
"multidisciplinary trainees",
"art nanotechnology",
"Farokhzad",
"postdoctoral fellows",
"nanotechnology components",
"Costa",
"Brigham",
"Women's Hospital",
"atherosclerosis",
"diagnostic imaging",
"nanotechnology",
"Fisher",
"theranostic nanoparticle platform",
"stage",
"Langer",
"infarction",
"Project 3",
"defective inflammation resolution",
"evaluation",
"excellence",
"next generation",
"regeneration factor",
"investigators",
"balance",
"Columbia",
"Project 1",
"CARDIAC &VASCULAR DIS",
"translational nanotechnology",
"NHLBI Programs",
"translational potential",
"MIT",
"training",
"Massachusetts Institute",
"MSSM",
"TAS::75 0872::TAS",
"vascular biology",
"multidisciplinary skills",
"tool",
"cardiovascular disease",
"atherosclerotic inflammatory process",
"context",
"Project 2",
"technology",
"PEN application",
"tissue engineering",
"Fuster",
"drug delivery",
"Zahi Fayad",
"TRANSLATIONAL NANOMEDICALTHERAPIES",
"engineers",
"clinical translation",
"project",
"heart failure",
"myocardial regeneration",
"different investigators",
"burden",
"synergistic interaction",
"aforementioned cardiovascular diseases",
"medicine",
"clinicians",
"Tabas",
"Hajjar",
"bioengineering",
"New York University",
"treatment",
"Columbia University",
"state",
"imaging"
],
"name": "TAS::75 0872::TAS TRANSLATIONAL NANOMEDICALTHERAPIES FOR CARDIAC &VASCULAR DIS",
"recipient": [
{
"id": "https://www.grid.ac/institutes/grid.59734.3c",
"type": "Organization"
},
{
"affiliation": {
"id": "https://www.grid.ac/institutes/grid.59734.3c",
"name": "ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI",
"type": "Organization"
},
"familyName": "FAYAD",
"givenName": "ZAHI",
"id": "sg:person.0772637666.38",
"type": "Person"
},
{
"member": "sg:person.0772637666.38",
"roleName": "PI",
"type": "Role"
}
],
"sameAs": [
"https://app.dimensions.ai/details/grant/grant.2345462"
],
"sdDataset": "grants",
"sdDatePublished": "2019-03-07T11:56",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects.xml.gz",
"startDate": "2010-08-13T00:00:00Z",
"type": "MonetaryGrant",
"url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=8175621"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2345462'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2345462'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2345462'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2345462'
This table displays all metadata directly associated to this object as RDF triples.
153 TRIPLES
19 PREDICATES
129 URIs
120 LITERALS
5 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:grant.2345462 | schema:about | anzsrc-for:2209 |
2 | ″ | ″ | anzsrc-for:2211 |
3 | ″ | schema:amount | N1b1aabe3952d433c8c7236158821b0c0 |
4 | ″ | schema:description | The overall goal of this PEN application is the development and imaging-facilitated evaluation of translational nanotechnology-based tools, and the development of associated multidisciplinary trainees, focused on the treatment of heart failure and atherosclerosis. We will apply nanotechnology to address the aforementioned cardiovascular diseases and integrate expertise in multiple disciplines, including vascular biology, tissue engineering, drug delivery, molecular biology, diagnostic imaging, chemistry, physics, bioengineering, and clinical sciences. Our multidisciplinary team includes investigators from Mount Sinai School of Medicine (MSSM), Massachusetts Institute of Technology (MIT), New York University (NYU), Columbia University (Columbia), and Brigham and Women's Hospital (BWH). Under the leadership of Zahi Fayad (MSSM) and Robert Langer (MIT), the application is structured to facilitate a synergistic interaction among the different investigators, to maximize clinical translation of the nanotechnology to biomedical and clinical problems, to optimize the design of nanotechnology components, and to train the next generation of engineers, scientists, and clinicians with the multidisciplinary skills to exploit nanotechnology towards eliminating the burdens of cardiovascular disease. The program consists of 3 innovative and translational research projects that utilize nanotechnology to tackle specific cardiac and vascular problems and thereby treat cardiovascular disease. Project 1 (Hajjar, Langer, Costa) will investigate minimally invasive nanotechnology-based approaches to deliver regeneration factors to the infarcted myocardium. In Project 2 (Fisher, Tabas, Langer, Farokhzad) novel nanotherapeutic approaches for defective inflammation resolution in atherosclerosis will be developed. Project 3 (Fayad, Mulder, Fuster, Langer) will develop a theranostic nanoparticle platform with surface activation properties to efficiently and specifically target and image macrophages in atherosclerotic plaques. All projects have a high degree of translational potential as well as a strong emphasis on developing state-of-the-art nanotechnology, with the balance between translation and technology varying among the 3 projects to create attractive and diverse platforms that are aligned with the overall goal of the NHLBI Programs of Excellence in Nanotechnology. Moreover, we chose to focus the different projects at two stages of cardiovascular disease, namely the (early) atherosclerotic inflammatory process and (late) myocardial regeneration after infarction. All 3 projects offer outstanding opportunities for the training and professional development of graduate students and postdoctoral fellows with the multidisciplinary skills required to apply nanotechnology in the context of cardiovascular disease. |
5 | ″ | schema:endDate | 2015-08-12T00:00:00Z |
6 | ″ | schema:funder | https://www.grid.ac/institutes/grid.279885.9 |
7 | ″ | schema:identifier | N1c8227b24e464c3486ded86a4813ca52 |
8 | ″ | ″ | N71087f1ac9e7487a903788921c574b8e |
9 | ″ | schema:inLanguage | en |
10 | ″ | schema:keywords | BWH |
11 | ″ | ″ | Brigham |
12 | ″ | ″ | CARDIAC &VASCULAR DIS |
13 | ″ | ″ | Columbia |
14 | ″ | ″ | Columbia University |
15 | ″ | ″ | Costa |
16 | ″ | ″ | Farokhzad |
17 | ″ | ″ | Fayad |
18 | ″ | ″ | Fisher |
19 | ″ | ″ | Fuster |
20 | ″ | ″ | Hajjar |
21 | ″ | ″ | Langer |
22 | ″ | ″ | MIT |
23 | ″ | ″ | MSSM |
24 | ″ | ″ | Massachusetts Institute |
25 | ″ | ″ | Mount Sinai School |
26 | ″ | ″ | Mulder |
27 | ″ | ″ | NHLBI Programs |
28 | ″ | ″ | New York University |
29 | ″ | ″ | PEN application |
30 | ″ | ″ | Project 1 |
31 | ″ | ″ | Project 2 |
32 | ″ | ″ | Project 3 |
33 | ″ | ″ | Robert Langer |
34 | ″ | ″ | TAS::75 0872::TAS |
35 | ″ | ″ | TRANSLATIONAL NANOMEDICALTHERAPIES |
36 | ″ | ″ | Tabas |
37 | ″ | ″ | Women's Hospital |
38 | ″ | ″ | Zahi Fayad |
39 | ″ | ″ | aforementioned cardiovascular diseases |
40 | ″ | ″ | application |
41 | ″ | ″ | approach |
42 | ″ | ″ | art nanotechnology |
43 | ″ | ″ | atherosclerosis |
44 | ″ | ″ | atherosclerotic inflammatory process |
45 | ″ | ″ | atherosclerotic plaques |
46 | ″ | ″ | balance |
47 | ″ | ″ | bioengineering |
48 | ″ | ″ | burden |
49 | ″ | ″ | cardiovascular disease |
50 | ″ | ″ | chemistry |
51 | ″ | ″ | clinical problems |
52 | ″ | ″ | clinical science |
53 | ″ | ″ | clinical translation |
54 | ″ | ″ | clinicians |
55 | ″ | ″ | context |
56 | ″ | ″ | defective inflammation resolution |
57 | ″ | ″ | design |
58 | ″ | ″ | development |
59 | ″ | ″ | diagnostic imaging |
60 | ″ | ″ | different investigators |
61 | ″ | ″ | different projects |
62 | ″ | ″ | diverse platforms |
63 | ″ | ″ | drug delivery |
64 | ″ | ″ | engineers |
65 | ″ | ″ | evaluation |
66 | ″ | ″ | excellence |
67 | ″ | ″ | expertise |
68 | ″ | ″ | graduate students |
69 | ″ | ″ | heart failure |
70 | ″ | ″ | high degree |
71 | ″ | ″ | imaging |
72 | ″ | ″ | infarction |
73 | ″ | ″ | invasive nanotechnology |
74 | ″ | ″ | investigators |
75 | ″ | ″ | leadership |
76 | ″ | ″ | macrophages |
77 | ″ | ″ | medicine |
78 | ″ | ″ | molecular biology |
79 | ″ | ″ | multidisciplinary skills |
80 | ″ | ″ | multidisciplinary team |
81 | ″ | ″ | multidisciplinary trainees |
82 | ″ | ″ | multiple disciplines |
83 | ″ | ″ | myocardial regeneration |
84 | ″ | ″ | myocardium |
85 | ″ | ″ | nanotechnology |
86 | ″ | ″ | nanotechnology components |
87 | ″ | ″ | nanotherapeutic approaches |
88 | ″ | ″ | next generation |
89 | ″ | ″ | novel |
90 | ″ | ″ | outstanding opportunity |
91 | ″ | ″ | overall goal |
92 | ″ | ″ | physics |
93 | ″ | ″ | postdoctoral fellows |
94 | ″ | ″ | professional development |
95 | ″ | ″ | program |
96 | ″ | ″ | project |
97 | ″ | ″ | regeneration factor |
98 | ″ | ″ | scientists |
99 | ″ | ″ | stage |
100 | ″ | ″ | state |
101 | ″ | ″ | strong emphasis |
102 | ″ | ″ | surface activation properties |
103 | ″ | ″ | synergistic interaction |
104 | ″ | ″ | technology |
105 | ″ | ″ | theranostic nanoparticle platform |
106 | ″ | ″ | tissue engineering |
107 | ″ | ″ | tool |
108 | ″ | ″ | training |
109 | ″ | ″ | translation |
110 | ″ | ″ | translational nanotechnology |
111 | ″ | ″ | translational potential |
112 | ″ | ″ | translational research projects |
113 | ″ | ″ | treatment |
114 | ″ | ″ | vascular biology |
115 | ″ | ″ | vascular problems |
116 | ″ | schema:name | TAS::75 0872::TAS TRANSLATIONAL NANOMEDICALTHERAPIES FOR CARDIAC &VASCULAR DIS |
117 | ″ | schema:recipient | N28eca57d6ffc43d58a23ce8b2ce5b575 |
118 | ″ | ″ | sg:person.0772637666.38 |
119 | ″ | ″ | https://www.grid.ac/institutes/grid.59734.3c |
120 | ″ | schema:sameAs | https://app.dimensions.ai/details/grant/grant.2345462 |
121 | ″ | schema:sdDatePublished | 2019-03-07T11:56 |
122 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
123 | ″ | schema:sdPublisher | Nf3784f076f264cd6b0f90d9ffa0b6931 |
124 | ″ | schema:startDate | 2010-08-13T00:00:00Z |
125 | ″ | schema:url | http://projectreporter.nih.gov/project_info_description.cfm?aid=8175621 |
126 | ″ | sgo:license | sg:explorer/license/ |
127 | ″ | sgo:sdDataset | grants |
128 | ″ | rdf:type | schema:MonetaryGrant |
129 | N1b1aabe3952d433c8c7236158821b0c0 | schema:currency | USD |
130 | ″ | schema:value | 16447515 |
131 | ″ | rdf:type | schema:MonetaryAmount |
132 | N1c8227b24e464c3486ded86a4813ca52 | schema:name | nih_id |
133 | ″ | schema:value | 268201000045C-0-0-1 |
134 | ″ | rdf:type | schema:PropertyValue |
135 | N28eca57d6ffc43d58a23ce8b2ce5b575 | schema:member | sg:person.0772637666.38 |
136 | ″ | schema:roleName | PI |
137 | ″ | rdf:type | schema:Role |
138 | N71087f1ac9e7487a903788921c574b8e | schema:name | dimensions_id |
139 | ″ | schema:value | 2345462 |
140 | ″ | rdf:type | schema:PropertyValue |
141 | Nf3784f076f264cd6b0f90d9ffa0b6931 | schema:name | Springer Nature - SN SciGraph project |
142 | ″ | rdf:type | schema:Organization |
143 | anzsrc-for:2209 | schema:inDefinedTermSet | anzsrc-for: |
144 | ″ | rdf:type | schema:DefinedTerm |
145 | anzsrc-for:2211 | schema:inDefinedTermSet | anzsrc-for: |
146 | ″ | rdf:type | schema:DefinedTerm |
147 | sg:person.0772637666.38 | schema:affiliation | https://www.grid.ac/institutes/grid.59734.3c |
148 | ″ | schema:familyName | FAYAD |
149 | ″ | schema:givenName | ZAHI |
150 | ″ | rdf:type | schema:Person |
151 | https://www.grid.ac/institutes/grid.279885.9 | ″ | schema:Organization |
152 | https://www.grid.ac/institutes/grid.59734.3c | schema:name | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
153 | ″ | rdf:type | schema:Organization |